Condition
Nasal Surgical Procedures
Total Trials
6
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
33%
2 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (1)
P 2 (2)
P 3 (1)
P 4 (1)
Trial Status
Not Yet Recruiting2
Completed2
Enrolling By Invitation1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07740655Phase 4Not Yet Recruiting
Low-dose Versus Standard-dose Remimazolam for Prevention of Emergence Agitation After Nasal Surgery
NCT04194216Phase 3Enrolling By Invitation
Antibiotic Prophylaxis in Rhinoplasty
NCT05273060Not ApplicableCompletedPrimary
Regenerative Medicine Approach to Nasal Reconstruction
NCT06885801Phase 2Not Yet Recruiting
Evaluation of a Novel Nasal Conformer in Pediatric Patients
NCT02822781Completed
Chronic Rhinosinusitis Classification Proposal
NCT02062996Phase 2Withdrawn
Hemodynamic and Pharmacokinetic Analysis of Oxymetazoline Absorption
Showing all 6 trials